Combatting Misinformation: FDA’s Califf On Use Of Facts, Opinion And Emotion

As discussion continues on the role of artificial intelligence in tackling misinformation and who gets to decide what information AI synthesizes, Califf and CBER’s Peter Marks call on clinical and biomedical community to dilute misinformation about vaccines with large amounts of scientific evidence.

Covid-19 misinformation
FDA is navigating how to counter misinformation and urging the biomedical community to promote scientific evidence on vaccines • Source: Shutterstock

More from AI

More from Advanced Technologies